Should I Buy JRSH? JRSH 2026 Analysis

Should You Buy Jerash Holdings (US) Inc (JRSH) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

3.070

1 Day change

52 Week Range

4.110

Analysis Updated At

2026/01/29

JRSH is not a good buy right now for an impatient investor. The technical setup is neutral-to-weak with limited upside room near resistance, probabilistic trend data points to further downside over the next week/month, and there are no strong proprietary trading signals or near-term positive catalysts to justify immediate entry.

Technical Analysis

Price/levels: JRSH closed at 3.07, essentially sitting on the pivot (3.071). Immediate resistance is tight overhead at 3.11 (R1) then 3.134 (R2); support is close below at 3.033 (S1) then 3.009 (S2). This creates a narrow range with unfavorable reward-to-risk for chasing a quick move up. Momentum: MACD histogram is slightly positive (0.00229) but positively contracting, indicating bullish momentum is fading rather than strengthening. RSI(6) at 46.04 is neutral, confirming lack of trend strength. Trend: Converging moving averages suggest consolidation/chop rather than a clean uptrend. Quant/pattern outlook: Similar-pattern analysis indicates a 70% chance of -0.56% next day, -2.61% next week, and -5.08% next month, reinforcing a near-term downside bias. **Intellectia Proprietary Trading Signals** - [AI Stock Picker](module://ai_stock_pick): No signal on given stock today. - [SwingMax](module://swingmax): No signal on given stock today.

Options Data

Positive Catalysts

Scheduled earnings event: QDec 2025 earnings on 2026-02-10 (pre-market) can act as a catalyst if results/forward commentary improve.
Revenue growth is positive (2026/Q2 revenue +4.30% YoY), which could support sentiment if margins stabilize.

Neutral/Negative Catalysts

Earnings risk ahead of 2026-02-10: recent profitability trends are weakening, raising the risk of disappointment.
Recent quarter deterioration: net income -29.56% YoY, EPS -20% YoY, and gross margin down to 14.99% (-14.54% YoY) suggest margin pressure.
No supportive flow signals: hedge funds and insiders are neutral with no significant recent trend.
Pattern-based probabilities point to further downside over 1 week and 1 month.

Financial Performance

Latest quarter: 2026/Q2. Revenue increased to 41,968,534 (+4.30% YoY), but profitability weakened: net income fell to 461,605 (-29.56% YoY) and EPS declined to 0.04 (-20.00% YoY). Gross margin dropped to 14.99% (down -14.54% YoY), indicating margin compression despite top-line growth.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so a clear Wall Street pros/cons consensus cannot be confirmed from the dataset. Based on the available fundamentals alone: the bull case is modest revenue growth; the bear case is deteriorating margins and earnings, which typically limits upside until improvement is visible.

1 Analyst Rating

Wall Street analysts forecast JRSH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for JRSH is 5 USD with a low forecast of 5 USD and a high forecast of 5 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

0 Hold

0 Sell

Moderate Buy

Current: 3.070

Low

Averages

High